journal article·2026-03-01Open access

Mechanical function of scaffold-free cardiac tissue fabricated using a temperature-responsive culture dish depends on the degree of shrinkage and load

Shohei Nishina, Tetsutaro Kikuchi, Katsuhisa Matsuura, Tatsuya Shimizu

Biofabrication· Volume 18· Issue 1

Abstract

Abstract Cardiac tissues derived from human-induced pluripotent stem cells (hiPSCs) are a promising platform for physiological modeling and drug screening. Among the various strategies used to recreate the in vivo environment for cardiac tissues, mechanical stress has been widely studied for its diverse effects. However, the effects of cellular structure and mechanical loading on the function of scaffold-free tissues remain unclear. Scaffold-free cardiac tissues were fabricated by layering hiPSC-derived cardiomyocytes onto human cardiac fibroblasts in temperature-responsive culture dishes. These tissues were harvested and cultured under fixed tissue lengths (representing the degree of shrinkage) and afterloads (resistance against contraction) in a newly designed culture and measurement device capable of measuring the tensional force under various tissue lengths and afterloads. The contractile force, tissue stiffness, morphology, and gene expression were evaluated. Double-layered cells formed in a ring shape were mounted onto the device in a bundle shape, enabling the measurement of contractile forces generated by spontaneous beating. Additionally, increased contractile force was observed in response to both stretching and β -adrenergic stimulation. The contractile force was influenced by the degree of shrinkage. Tissues set at shorter lengths (greater shrinkage) exhibited significantly reduced force and did not recover by day 7. Additionally, tissues cultured under higher afterloads displayed significantly increased contractile forces and stiffness. Our findings demonstrate that both the initial shrinkage and afterload magnitude critically influence the mechanical function of scaffold-free cardiac tissues. These results highlight the importance of controlling the mechanical environment in scaffold-free tissue engineering.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · 3D Printing in Biomedical Research · Pluripotent Stem Cells Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (73)

Show source-provided references
1. Present and future challenges of induced pluripotent stem cells10.1098/rstb.2014.0367 ↗
2. Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility10.1016/j.pbiomolbio.2012.07.013 ↗
3. Human engineered heart tissue models for disease modeling and drug discovery10.3389/fcell.2022.855763 ↗
4. A brief review of current maturation methods for human induced pluripotent stem cells-derived cardiomyocytes10.3389/fcell.2020.00178 ↗
5. Progressive stretch enhances growth and maturation of 3D stem-cell-derived myocardium10.7150/thno.54999 ↗
6. Thyroid and glucocorticoid hormones promote functional T-tubule development in human-induced pluripotent stem cell-derived cardiomyocytes10.1161/CIRCRESAHA.117.311920 ↗
7. Substrate stiffness influences structural and functional remodeling in induced pluripotent stem cell-derived cardiomyocytes10.3389/fphys.2021.710619 ↗
8. Aligned human induced pluripotent stem cell-derived cardiac tissue improves contractile properties through promoting unidirectional and synchronous cardiomyocyte contraction10.1016/j.biomaterials.2021.121351 ↗
9. Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue10.1161/CIRCULATIONAHA.114.014998 ↗
10. Layer-by-layer fabrication of large and thick human cardiac muscle patch constructs with superior electrophysiological properties10.3389/fcell.2021.670504 ↗
11. Recent advances in maturation of pluripotent stem cell-derived cardiomyocytes promoted by mechanical stretch10.12659/MSM.931063 ↗
12. Advanced maturation of human cardiac tissue grown from pluripotent stem cells10.1038/s41586-018-0016-3 ↗
13. Pneumatic unidirectional cell stretching device for mechanobiological studies of cardiomyocytes10.1007/s10237-019-01211-8 ↗
14. Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine10.1038/s41569-019-0331-x ↗
15. Current strategies of mechanical stimulation for maturation of cardiac microtissues10.1007/s12551-021-00841-6 ↗
16. Cardiac tissues from stem cells: new routes to maturation and cardiac regeneration10.1161/CIRCRESAHA.121.318183 ↗
17. Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues10.1016/j.yjmcc.2018.03.016 ↗
18. Advances in cardiac tissue engineering and heart-on-a-chip10.1002/jbm.a.37633 ↗
19. Cardiac tissue engineering: multiple approaches and potential applications10.3389/fbioe.2022.980393 ↗
20. Scaffold-free cell-based tissue engineering therapies: advances, shortfalls and forecast10.1038/s41536-021-00133-3 ↗
21. Emergence of scaffold-free approaches for tissue engineering musculoskeletal cartilages10.1007/s10439-014-1161-y ↗
22. Human engineered heart tissue: analysis of contractile force10.1016/j.stemcr.2016.04.011 ↗
23. Recent advances in cell sheet engineering: from fabrication to clinical translation10.3390/bioengineering10020211 ↗
24. Cell sheet mechanics: how geometrical constraints induce the detachment of cell sheets from concave surfaces10.1016/j.actbio.2016.08.044 ↗
25. A novel method to align cells in a cardiac tissue-like construct fabricated by cell sheet-based tissue engineering10.1002/term.3074 ↗
26. Case report: transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy10.3389/fcvm.2022.950829 ↗
27. Importance of beating rate control for the analysis of drug effects on contractility in human induced pluripotent stem cell-derived cardiomyocytes10.1016/j.vascn.2022.107228 ↗
28. Cardiomyocyte-fibroblast crosstalk in the postnatal heart10.3389/fcell.2023.1163331 ↗
29. Cardiac tissue engineering: inclusion of non-cardiomyocytes for enhanced features10.3389/fcell.2021.653127 ↗
30. Cardiac fibroblast-mediated ECM remodeling regulates maturation in an in vitro 3D engineered cardiac tissue10.1177/20417314251356321 ↗
31. Cardiac fibroblast-derived VCAM-1 enhances cardiomyocyte proliferation for fabrication of bioengineered cardiac tissue10.1016/j.reth.2016.01.005 ↗
32. Phenotypic variation between stromal cells differentially impacts engineered cardiac tissue function10.1089/ten.tea.2018.0362 ↗
33. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors10.1016/j.cell.2006.07.024 ↗
34. Creation of human cardiac cell sheets using pluripotent stem cells10.1016/j.bbrc.2012.07.089 ↗
35. TRPV-1-mediated elimination of residual iPS cells in bioengineered cardiac cell sheet tissues10.1038/srep21747 ↗
36. Glutamine oxidation is indispensable for survival of human pluripotent stem cells10.1016/j.cmet.2016.03.001 ↗
37. Biomaterial-free three-dimensional bioprinting of cardiac tissue using human induced pluripotent stem cell derived cardiomyocytes10.1038/s41598-017-05018-4 ↗
38. Drug response analysis for scaffold-free cardiac constructs fabricated using bio-3D printer10.1038/s41598-020-65681-y ↗
39. Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture10.1038/s41598-022-22225-w ↗
40. Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration10.1038/srep06716 ↗
41. One billion hiPSC-cardiomyocytes: upscaling engineered cardiac tissues to create high cell density therapies for clinical translation in heart regeneration10.3390/bioengineering10050587 ↗
42. The inter-sample structural variability of regular tissue-engineered scaffolds significantly affects the micromechanical local cell environment10.1098/rsfs.2014.0097 ↗
43. Advances in engineering human tissue models10.3389/fbioe.2020.620962 ↗
44. Engineering thick cell sheets by electrochemical desorption of oligopeptides on membrane substrates10.1016/j.reth.2015.12.003 ↗
45. Contractile force measurement of human induced pluripotent stem cell-derived cardiac cell sheet-tissue10.1371/journal.pone.0198026 ↗
46. Densely vascularized thick 3D tissue shows enhanced protein secretion constructed with intermittent positive pressure10.1038/s42003-025-07627-6 ↗
47. In vitro ballooned hepatocytes can be produced by primary human hepatocytes and hepatic stellate cell sheets10.1038/s41598-022-09428-x ↗
48. Development of a three-dimensional pre-vascularized scaffold-free contractile cardiac patch for treating heart disease10.1016/j.healun.2015.06.001 ↗
49. Optimizing blended collagen-fibrin hydrogels for cardiac tissue engineering with human iPSC-derived cardiomyocytes10.1021/acsbiomaterials.8b01112 ↗
50. Stimulating calcium handling in hiPSC-derived engineered cardiac tissues enhances force production10.1093/stcltm/szab002 ↗
51. ROCK inhibitor combined with Ca2+ controls the myosin II activation and optimizes human nasal epithelial cell sheets10.1038/s41598-020-73817-3 ↗
52. Increased afterload induces pathological cardiac hypertrophy: a new in vitro model10.1007/s00395-012-0307-z ↗
53. 3D co-culture of hiPSC-derived cardiomyocytes with cardiac fibroblasts improves tissue-like features of cardiac spheroids10.3389/fmolb.2020.00014 ↗
54. Vascular cells improve functionality of human cardiac organoids10.1016/j.celrep.2023.112322 ↗
55. Dynamic loading of human engineered heart tissue enhances contractile function and drives a desmosome-linked disease phenotype10.1126/scitranslmed.abd1817 ↗
56. Development of a drug screening system using three-dimensional cardiac tissues containing multiple cell types10.1038/s41598-021-85261-y ↗
57. Self-organization of human hepatic organoid by recapitulating organogenesis in vitro10.1016/j.transproceed.2012.02.007 ↗
58. Human-iPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease10.1016/j.stem.2020.05.004 ↗
59. hiPSC-derived cardiac fibroblasts dynamically enhance the mechanical function of hiPSC-derived cardiomyocytes on an engineered substrate10.3389/fbioe.2025.1546483 ↗
60. Human myofibroblasts increase the arrhythmogenic potential of human induced pluripotent stem cell-derived cardiomyocytes10.1007/s00018-023-04924-3 ↗
61. Fibroblasts in heart scar tissue directly regulate cardiac excitability and arrhythmogenesis10.1126/science.adh9925 ↗
62. The Frank–Starling law: a jigsaw of titin proportions10.1007/s12551-017-0272-8 ↗
63. Titin and troponin: central players in the Frank-Starling mechanism of the heart10.2174/157340309788166714 ↗
64. Titin-based force modulates cardiac thick and thin filaments10.1161/CIRCRESAHA.123.323988 ↗
65. Titin governs myocardial passive stiffness with major support from microtubules and actin and the extracellular matrix10.1038/s44161-023-00348-1 ↗
66. Focal adhesion’s role in cardiomyocytes function: from cardiomyogenesis to mechanotransduction10.3390/cells13080664 ↗
67. The role of the dystrophin glycoprotein complex in muscle cell mechanotransduction10.1038/s42003-022-03980-y ↗
68. The actin cortex: a bridge between cell shape and function10.1016/j.devcel.2016.09.011 ↗
69. Desmosomes at a glance10.1242/jcs.261899 ↗
70. Vinculin anchors contractile actin to the cardiomyocyte adherens junction10.1091/mbc.E19-04-0216 ↗
71. Transforming growth factor (TGF)-β signaling in cardiac remodeling10.1016/j.yjmcc.2010.10.033 ↗
72. Supply of nutrients to cells in engineered tissues10.5661/bger-26-163 ↗
73. Extracellular matrix protein ratios in the human heart and vessels: how to distinguish pathological from physiological changes?10.3389/fphys.2021.708656 ↗